false
OasisLMS
Catalog
SCCM Resource Library
Late-Breaking Studies Affecting Patient Outcomes I ...
Late-Breaking Studies Affecting Patient Outcomes II
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This session highlighted four significant presentations impacting patient outcomes in critical care:<br /><br />1. Dr. Lars Palmowski presented research on the "Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients." The study revealed that unnecessary PPI continuation post-discharge increased morbidity, re-hospitalization (by 35%), and mortality (by 17%).<br /><br />2. Dr. Gayan Kayaster discussed the reduction of antibiotic duration for ventilator-associated pneumonia (VAP) through the RIGAV-BAP trial. The trial indicated that short-course antibiotic treatments were non-inferior to longer treatments, reducing side effects, antibiotic use, and costs, especially in low-income settings.<br /><br />3. Dr. Nazima Pathan presented the pediatric arm of the recovery trial for PIMS-TS associated with COVID-19. Findings suggested methylprednisolone significantly reduced hospital stay and inflammation compared to IVIG. In severe cases, tocilizumab showed potential benefit but increased the need for inotropes.<br /><br />4. Dr. Loren Schlappach shared results from a pilot study on metabolic resuscitation using vitamin C, thiamine, and hydrocortisone in children with septic shock. The study demonstrated feasibility in implementing such trials, with promising results for metabolic adjunctive therapies, despite some methodological challenges.<br /><br />Overall, these studies emphasize the need for targeted interventions in critical care to improve both efficacy and safety of patient treatments.
Asset Caption
One-Hour Concurrent Session | Late-Breaking Studies Affecting Patient Outcomes II
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
critical care
patient outcomes
proton pump inhibitors
ventilator-associated pneumonia
antibiotic duration
PIMS-TS
metabolic resuscitation
COVID-19
pediatric trials
×
Please select your language
1
English